Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
quadrivalent split influenza virus vaccine (Ab&B Bio-tech Co., Ltd.)
- Development stage
- Unknown
- Lead developer
- Hualan Biological Vaccine
- Modality
- Vaccines & Immunotherapeutics
- Administration
- Intramuscular
01
Overview
A quadrivalent split-virion influenza vaccine developed by Ab&B Bio-Tech Co., Ltd. JS. It is an inactivated vaccine containing hemagglutinin antigens from four distinct influenza virus strains: two Influenza A subtypes (H1N1 and H3N2) and two Influenza B lineages (Victoria and Yamagata). The vaccine works by inducing the production of hemagglutination inhibition (HI) antibodies against these surface antigens, providing active immunity to prevent seasonal influenza. In clinical trials, such as NCT05645900, it has been utilized as an active comparator to evaluate the safety and immunogenicity of novel influenza vaccine candidates in pediatric populations aged 6 to 35 months.
- Other names
- Quadrivalent Split Influenza Virus Vaccinesplit-virion quadrivalent influenza vaccine
02
Targets
HA (Hemagglutinin)
Beyond the preview
Go deeper on quadrivalent split influenza virus vaccine (Ab&B Bio-tech Co., Ltd.).
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on quadrivalent split influenza virus vaccine (Ab&B Bio-tech Co., Ltd.).